Syncom Formulations (India) Ltd: A Smallcap Pharma Company Making Waves in the Stock Market
Syncom Formulations (India) Ltd, a smallcap pharmaceutical company, has been performing exceptionally well in the stock market. Its stock price reached an all-time high on August 22, 2024, and is currently trading close to its 52-week high. The company has consistently outperformed the sector and its moving averages, showcasing its strong growth and stability. In the past year, its stock has outperformed the Sensex by a significant margin, making it a promising investment option in the pharma industry.
Syncom Formulations (India) Ltd, a smallcap pharmaceutical company, has been making waves in the stock market with its recent performance. On August 22, 2024, the company's stock price reached an all-time high, signaling positive growth and potential for investors.
According to MarketsMOJO, a leading stock market analysis platform, Syncom Formulations (India) Ltd is a 'Buy' call. The stock is currently trading close to its 52-week high of Rs 19.53, with a 0.67% difference. In today's trading, the stock has outperformed the sector by 1.07%, showcasing its strong performance.
The company has been on a winning streak, with its stock gaining for the last four consecutive days and delivering a remarkable 24.92% returns in this period. This is a clear indication of the company's consistent growth and stability.
Moreover, Syncom Formulations (India) Ltd is currently trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, further solidifying its strong performance in the market.
In the past year, the company's stock has outperformed the Sensex by a significant margin, with a 118.44% growth compared to the Sensex's 24.26% performance. This showcases the company's strong potential and growth trajectory.
With its impressive performance and consistent growth, Syncom Formulations (India) Ltd is definitely a stock to watch out for in the pharma industry. Investors can consider adding this smallcap company to their portfolio for potential long-term gains.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
